Corcept Therapeutics CORT
NASDAQ CORT
$111.62 -1.18 (-1.05%)
As of: Sep 4, 2026 · 3:59 PM EDT

Corcept Therapeutics (CORT) Gross Margin Growth (1y) (2013 - 2026)

Analysis

Corcept Therapeutics (CORT) Gross Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -93.00
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -91.00
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 210.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1,966.00
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 228.00
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -475.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1,034.00
10 Corcept Therapeutics 11.76 Bn 11.46 Bn 252.09 Mn 18.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.00
Mar 31, 2026 -22.00
Dec 31, 2025 37.00
Sep 30, 2025 -64.00
Jun 30, 2025 -22.00
Mar 31, 2025 20.00
Dec 31, 2024 -24.00
Sep 30, 2024 -24.00
Jun 30, 2024 -20.00
Mar 31, 2024 -41.00
Dec 31, 2023 5.00
Sep 30, 2023 -1.00
Jun 30, 2023 -6.00
Mar 31, 2023 2.00
Dec 31, 2022 -7.00
Sep 30, 2022 1.00
Jun 30, 2022 24.00
Mar 31, 2022 26.00
Dec 31, 2021 9.00
Sep 30, 2021 8.00